Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 11 sales; 1,344 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.60M in total
- 11
- 13F holdersQ2 2026, +65 vs. previous quarter
- 1,344
- 13F valueReported value at the end of Q2 2026
- $47.2B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding EW, Q2 2026
No superinvestor reported holding EW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Edwards Lifesciences Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 (view filing)7:15 PM ET | Sep 11 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $87.51 | −$54.2K | −1.5%40.0K after | 10b5-1 |
| Aug 31, 2026 (view filing)5:47 PM ET | Aug 31 | Same day | Dahl Andrew M.SVP, Corporate Controller | SSale | −544 | $91.06 | −$49.5K | −3.5%14.9K after | |
| Aug 28, 2026 (view filing)4:32 PM ET | Aug 28 | Same day | Bruls AnnetteCVP, EMEACLA | SSale | −2.64K | $89.98 | −$237.9K | −12.8%18.0K after | |
| Aug 26, 2026 (view filing)6:36 PM ET | Aug 26 | Same day | Chopra DaveenCVP, TMTT, Surgical & IHFM | SSale | −31.8K | $91.02 | −$2.89M | −41.8%44.3K after | 2 lots |
| Aug 26, 2026 (view filing)6:00 PM ET | Aug 26 | Same day | Markowitz WayneCVP, JAPAC | SSale | −1.24K | $91.47 | −$113.4K | −5.8%20.3K after | |
| Aug 11, 2026 (view filing)5:07 PM ET | Aug 11 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $92.03 | −$57.0K | −1.5%40.0K after | 10b5-1 |
| Jul 30, 2026 (view filing)5:30 PM ET | Jul 30 | Same day | Markowitz WayneCVP, JAPAC | SSale | −146.31 | $86.03 | −$12.6K | −0.7%21.5K after | |
| Jul 28, 2026 (view filing)7:40 PM ET | Jul 28 | Same day | Markowitz WayneCVP, JAPAC | SSale | −9.63K | $85.06 | −$819.0K | −30.8%21.7K after | |
| Jul 27, 2026 (view filing)6:59 PM ET | Jul 27 | Same day | Zovighian Bernard JCEO | SSale | −2.92K | $83.93 | −$245.1K | −24.7%8.92K after | |
| Jul 10, 2026 (view filing)5:04 PM ET | Jul 10 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $91.70 | −$56.8K | −1.5%40.0K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Edwards Lifesciences Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 58,789,433 | $5.32B | 0.08% | +6,198,500+11.8% | Added |
| Vanguard Capital Management LLC | 37,615,952 | $3.40B | 0.07% | −111,840−0.3% | Reduced |
| Vanguard Portfolio Management LLC | 26,411,402 | $2.39B | 0.11% | +4,3840.0% | Added |
| State Street Corp | 26,321,940 | $2.38B | 0.07% | +25,541+0.1% | Added |
| JPMorgan Chase & Co | 22,783,175 | $2.08B | 0.12% | +1,038,463+4.8% | Added |
| Wellington Management Group LLP | 16,827,967 | $1.52B | 0.26% | −5,183,134−23.5% | Reduced |
| Geode Capital Management, LLC | 15,437,251 | $1.39B | 0.07% | +2,303,474+17.5% | Added |
| Bank of New York Mellon Corp | 14,084,483 | $1.27B | 0.21% | −2,653,065−15.9% | Reduced |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,002,965 | $1.18B | 0.92% | +191,063+1.5% | Added |
| Ninety One UK Ltd | 12,337,502 | $1.12B | 2.50% | −58,641−0.5% | Reduced |